![Mike Quirk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Mike Quirk worked as Director at AstraZeneca Pharmaceuticals LP from 2012 to 2014.
Dr. Quirk worked as Chief Scientific Officer at SAGE Therapeutics, Inc. from 2023 to 2025.
Dr. Quirk completed undergraduate and doctorate degrees at the Massachusetts Institute of Technology.
Former positions of Mike Quirk
| Companies | Position | End |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/07/2025 |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Director/Board Member | 30/04/2014 |
Training of Mike Quirk
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
24
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
- Stock Market
- Insiders
- Mike Quirk
